SREBF1 and cancer: The mammalian/mechanistic target of rapamycin complex 1 (mTORC1) regulates the transcription and translation of SREBP-1 and SREBP-2 to promote de novo lipid biosynthesis in response to nutrients or insulin, which regulate cell proliferation, mitochondrial metabolism, or glycolytic capacity in cancer (49, 50).